Intermolecular (IMI) Reports In-Line Q2 EPS; Issues Light Q3 Outlook

August 5, 2016 6:35 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Intermolecular (NASDAQ: IMI) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.2 million.

GUIDANCE:

Intermolecular sees Q3 2016 EPS of ($0.12)-($0.10), versus the consensus of ($0.03). Intermolecular sees Q3 2016 revenue of $9.5-10.0 million, versus the consensus of $14.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment